Stoke Therapeutics Approaches Critical Clinical and Financial Inflection Points
Investors in Stoke Therapeutics are monitoring a series of imminent catalysts as the company advances its clinical pipeline. The coming...
Investors in Stoke Therapeutics are monitoring a series of imminent catalysts as the company advances its clinical pipeline. The coming...
The Vanguard Small-Cap Value ETF, commonly cited by its ticker VBR, benefited from a notable sector rotation on the U.S....
FutureFuel heads into a pivotal stretch, with the upcoming release of 2025 annual results and the ramp-up of new capacity...
Analysts boosted their outlook for Almonty Industries after a pivotal milestone at the Sangdong tungsten project and fresh price-target revisions...
Apex Critical Metals is stepping up activity at its Rift Rare Earth project in Nebraska, deploying a second drill rig...
Fiserv has unveiled a new platform, INDX, aimed at letting institutional crypto players settle US dollars around the clock while...
BridgeBio Pharma announced yesterday the successful completion of the pivotal Phase 3 PROPEL 3 study evaluating Infigratinib. The data demonstrate...
Salesforce is undertaking a sweeping transformation, pruning roughly 1,000 roles across several divisions and revamping its leadership as it doubles...
Atreca, the biotechnology firm, is in the final phase of its wind-down and formal dissolution. Shareholders had already endorsed this...
Lynas Rare Earths Ltd. is experiencing a confluence of supportive factors, including rising commodity prices and increased geopolitical focus on...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com